Nektar Therapeutics
NKTR
NKTR
212 hedge funds and large institutions have $376M invested in Nektar Therapeutics in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
212
Holders Change
-16
Holders Change %
-7.02%
% of All Funds
3.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
67
Reduced
72
Closed
38
Calls
$48K
Puts
$33K
Net Calls
+$15K
Net Calls Change
-$1.77M
Top Buyers
| 1 |
1
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$5.81M |
| 2 |
2
Federated Hermes
Pittsburgh,
Pennsylvania
|
$4.19M |
| 3 |
ABG
3
Ally Bridge Group
New York
|
$3.02M |
| 4 |
4
BlackRock
New York
|
$81.2M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$4.25M |
